If you are aware of any such report, please do link to it and quote from it.Wasn’t there a report claiming that the Pfizer one wasn’t producing antibodies after 12 weeks in immune compromised individuals?
This does not make any sense to me.
Also, can you clarify what CEV means; assuming you mean clinically extremely vulnerable, this encompasses a huge range of individuals with varying conditions.I’d have to hunt it out. For “normal” people the 12 week gap was fine, and justified the decision to delay Pfizer until 12 weeks but there was definitely something about it being questionable for CEV.
If you are suggesting that antibody levels need to be kept high in some people, then I think we need more context here; most people do not need antibodies to be able to fight an infection. On the contrary, it is not healthy or normal to have antibodies for every virus we have immunity against to be constantly circulating in our bodies! What actually matters is the ability of memory B cells to recognise the virus and be able to produce antibodies as and when required, and for memory T cells to recognise & destroy infected cells and create more T cells.
A longer gap between doses is more is likely to improve the longevity and strength of this long term memory, compared to a shorter gap between doses.